Document is current
Any future updates will be listed below
-
Authors
Gale, RP https://orcid.org/0000-0002-9156-1676
Hochhaus, A.
- License Information
-
More Information
Article History
Received: 31 October 2024
Revised: 4 November 2024
Accepted: 5 November 2024
First Online: 13 December 2024
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. AH received research support by Novartis, BMS, Incyte, Pfizer and Enliven Pharma, RPG and AH are Editors-in-Chief of LEUKAEMIA.
Free to read: This content has been made available to all.
